V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190009779 | 190002847 | 1.9 | 73.5 | Curative (C) | 2021-01-19 | 2021-01-26 | EURAMOS TRIAL | 02 | N | TRIAL | 100310566 |
| 190009780 | 190002848 | null | null | null | null | 2018-05-28 | OST Euramos 1 Closed Trial - AP | null | null | OST AP | 100020687 |
| 190009781 | 190002849 | 1.56 | 86 | Palliative (P) | 2019-02-28 | 2019-03-08 | EURAMOS TRIAL | 02 | N | MAP | 100424351 |
| 190009788 | 190002852 | 1.75 | 54.75 | Curative (C) | 2019-05-18 | 2019-05-18 | Cisplatin + Doxorubicin | 02 | N | CISPLATIN + DOXORUBICIN | 100428625 |
| 190009789 | 190002853 | null | null | null | null | 2019-12-01 | OST Euramos 1 Closed Trial - AP | null | null | OST AP | 100968835 |
| 190009793 | 190002854 | null | null | null | null | 2017-09-06 | Irinotecan + Modified De Gramont | null | null | FLUOROURACIL + OXALIPLATIN | 100112512 |
| 190009799 | 190002855 | null | null | null | null | 2016-07-05 | Cisplatin + Doxorubicin | null | null | CISPLATIN + DOXORUBICIN | 100727432 |
| 190009801 | 190002856 | null | null | null | null | 2021-04-12 | VDC | null | null | EURAMOS TRIAL | 101205250 |
| 190009805 | 190002857 | 1.61 | 104.3 | Curative (C) | 2019-04-19 | 2019-04-22 | ETOPOSIDE + IFOSFAMIDE | 02 | N | EURAMOS TRIAL | 100410947 |
| 190009807 | 190002858 | null | null | null | null | 2022-02-07 | EW EuroEwing 2012 Arm A VIDE | null | null | EURAMOS TRIAL | 100328378 |
| 190009811 | 190002859 | null | null | null | null | 2017-11-18 | Gemcitabine + Capecitabine | null | null | VIDE | 100797259 |
| 190009815 | 190002861 | 0 | 54 | Palliative (P) | 2019-11-03 | 2019-11-04 | Cisplatin + Doxorubicin | N | N | CISPLATIN + DOXORUBICIN | 101573241 |
| 190009817 | 190002862 | null | null | null | null | 2016-12-23 | Cisplatin + Doxorubicin | null | null | CISPLATIN + DOXORUBICIN | 101624875 |
| 190009824 | 190002865 | null | null | null | null | 2018-03-24 | EOX | null | null | MAP | 101041721 |
| 190009827 | 190002866 | null | null | null | null | 2018-05-05 | OST Euramos 1 Closed Trial - Ai | null | null | NIVOLUMAB | 100705069 |
| 190009831 | 190002869 | null | null | null | null | 2018-07-12 | EW EuroEwing 2012 Arm B VDC | null | null | EW EUROEWING 2012 ARM B VDC | 101813836 |
| 190009834 | 190002872 | 1.66 | 60.8 | Curative (C) | 2018-06-15 | 2018-06-15 | ECX | 02 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101779417 |
| 190009840 | 190002875 | null | null | null | null | 2018-06-19 | Cisplatin + Doxorubicin | null | null | CISPLATIN + DOXORUBICIN | 100295606 |
| 190009841 | 190002876 | null | null | null | null | 2016-07-19 | Carboplatin+Fluorouracil 4 or 5 day | null | null | EURO-EWING | 100215774 |
| 190009842 | 190002877 | 1.66 | 54.2 | Adjuvant (A) | 2017-01-10 | 2017-01-25 | OCTREOTIDE | 02 | N | EURO-EWING | 100070652 |
| 190009843 | 190002878 | null | null | null | null | 2017-06-21 | NB Low/Interm risk guidelines Carbo/Etop | null | null | DOXORUBICIN + METHOTREXATE | 101154844 |
| 190009848 | 190002879 | null | 124.5 | 03 | 2016-07-13 | 2016-08-07 | Cisplatin + Doxorubicin | 02 | N | CISPLATIN + DOXORUBICIN | 101123482 |
| 190009849 | 190002880 | null | null | null | null | 2017-07-19 | PAM x 2 pre-surgery (cycles 1&2) | null | null | CISPLATIN + DOXORUBICIN + METHOTREXATE | 100550613 |
| 190009852 | 190002881 | 1.81 | 91 | Curative (C) | 2019-05-01 | 2019-05-07 | PAM | 02 | N | CISPLATIN + DOXORUBICIN + METHOTREXATE | 101353404 |
| 190009854 | 190002882 | null | null | null | null | 2016-08-26 | OST Euramos 1 Closed Trial - AP | null | null | DOXORUBICIN + HD MTX | 100000105 |
| 190009855 | 190002883 | 1.68 | 63.2 | Curative (C) | 2019-09-23 | 2019-09-30 | EOX | null | Y | DOXORUBICIN + HD MTX | 101410807 |
| 190009856 | 190002884 | 1.59 | null | Neo-adjuvant (N) | 2020-10-08 | 2020-10-13 | OST Euramos 1 Closed Trial - Ai | Y | N | DOXORUBICIN + HD MTX | 100197413 |
| 190009857 | 190002885 | null | null | null | null | 2015-06-08 | EW EuroEwing 99 : VIDE | null | null | IFOSFAMIDE | 100491230 |
| 190009858 | 190002886 | null | null | null | 2020-05-10 | 2020-05-17 | Cisplatin + Doxorubicin | 02 | null | CISPLATIN + DOXORUBICIN | 100569096 |
| 190009872 | 190002889 | 1.77 | 78.2 | Curative (C) | 2016-01-18 | 2016-01-18 | GC Int Guide Excranial GermCell JEB | N | N | DOXORUBICIN + HD MTX | 101829072 |
| 190009873 | 190002890 | null | 12.5 | Neo-adjuvant (N) | 2018-06-09 | 2018-06-16 | OST Euramos 1 Closed Trial - AP | 01 | N | OST AP | 100717419 |
| 190009877 | 190002891 | 1.5 | 37.4 | Curative (C) | 2017-12-28 | 2017-12-29 | EW EuroEwing 2012 Arm B VDC | 02 | Y | EW EUROEWING 2012 ARM B VDC | 100950213 |
| 190009878 | 190002892 | 1.81 | 81.7 | Adjuvant (A) | 2018-06-05 | 2018-06-05 | EOX | 02 | null | DOXORUBICIN + METHOTREXATE | 100482626 |
| 190009881 | 190002893 | 1.68 | 114 | Curative (C) | 2019-10-02 | 2019-10-02 | CARBOPLATIN | 02 | null | IMATINIB | 101302257 |
| 190009882 | 190002894 | null | null | null | null | 2018-05-19 | Gemcitabine 1000mg/m2 D1 8 15 | null | null | DOXORUBICIN + HD MTX | 101714439 |
| 190009884 | 190002895 | 1.57 | 74.3 | Curative (C) | 2018-09-02 | 2018-09-02 | OCTREOTIDE | 02 | N | EURO-EWING | 101798406 |
| 190009898 | 190002897 | 1.52 | 94.5 | Palliative (P) | 2019-01-18 | 2019-01-19 | Cisplatin + Etoposide (3 day) | 02 | N | DOXORUBICIN + HD MTX | 101867610 |
| 190009900 | 190002898 | 1.61 | 75.8 | Neo-adjuvant (N) | 2019-04-05 | 2019-04-05 | Capecitabine + Oxaliplatin 21day | 02 | N | EURAMOS TRIAL | 100342782 |
| 190009904 | 190002899 | null | null | null | null | 2018-05-01 | CARBOPLATIN + GEMCITABINE | null | null | DOXORUBICIN + METHOTREXATE | 100212890 |
| 190009905 | 190002900 | 1.54 | 50.8 | Curative (C) | 2019-06-22 | 2019-06-27 | null | 02 | N | ABIRATERONE | 100935290 |
| 190009910 | 190002901 | 1.76 | null | Palliative (P) | 2016-03-04 | 2016-03-05 | OCTREOTIDE | 01 | N | CARBOPLATIN + ETOPOSIDE | 101791109 |
| 190009914 | 190002902 | null | null | null | null | 2018-08-01 | BEP 3 day | null | null | CAPECITABINE + CISPLATIN | 101292391 |
| 190009917 | 190002903 | 1.58 | 91 | null | 2018-04-15 | 2018-04-27 | Doxorubicin + Ifosfamide | 02 | null | FEC | 100316004 |
| 190009918 | 190002904 | null | null | null | null | 2018-03-30 | Cisplatin + Radiotherapy | null | null | EW EUROEWING 2012 ARM A VIDE | 101164110 |
| 190009928 | 190002905 | null | null | null | null | 2020-02-25 | GemCarbo Days 1+8 | null | null | NB HRNBL-1 COJEC IND COURSE A | 101608054 |
| 190009929 | 190002906 | 1.68 | 10.2 | Palliative (P) | 2016-03-29 | 2016-04-10 | FEC 100 | N | N | CASPS TRIAL | 100958520 |
| 190009931 | 190002907 | null | null | null | null | 2018-09-25 | Cisplatin + Doxorubicin | null | null | CISPLATIN + DOXORUBICIN | 100621537 |
| 190009932 | 190002908 | 1.62 | 53 | Palliative (P) | 2019-07-17 | 2019-07-31 | EW EuroEwing 2012 Arm B VDC | 02 | N | EW EUROEWING 2012 ARM B VDC | 101741327 |
| 190009940 | 190002909 | null | null | null | null | 2016-11-24 | CAPECITABINE + OXALIPLATIN | null | null | EW EUROEWING 2012 ARM A VIDE | 101142333 |
| 190009944 | 190002911 | null | null | null | null | 2016-09-21 | LANREOTIDE | null | null | DOXORUBICIN + HD MTX | 101284814 |